We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 915 results
  1. Clinical landscape of macrophage-reprogramming cancer immunotherapies

    Tumour-associated macrophages (TAMs) sustain a tumour-supporting and immunosuppressive milieu and therefore aggravate cancer prognosis. To modify TAM...

    Jenna H. Rannikko, Maija Hollmén in British Journal of Cancer
    Article Open access 03 June 2024
  2. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors

    An immunosuppressive tumor microenvironment (TME) leads to cancer growth, metastasis, and therapeutic resistance. Immunomodulatory immunotherapy aims...

    Maggie Musick, **anzhong Yu in Immunologic Research
    Article 29 April 2022
  3. Modulating and Imaging Macrophage Reprogramming for Cancer Immunotherapy

    Cancer immunotherapy has made great progress in effectively attacking or eliminating cancer. However, the challenges posed by the low reactivity of...

    Jialu Wang, Yafang Lu, ... Zhihong Zhang in Phenomics
    Article 22 June 2024
  4. CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming

    Background

    Tumor-associated macrophages (TAMs) constitute a substantial part of human hepatocellular carcinoma (HCC). The present study was devised to...

    Shiqi Liu, Shuairan Zhang, ... Gang Wu in BMC Cancer
    Article Open access 07 June 2024
  5. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming

    Macrophages are highly plastic in different tissues and can differentiate into functional subpopulations under different stimuli. Tumor-associated...

    Wentao Zeng, Fei Li, ... **n **e in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 September 2023
  6. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment

    Metabolic reprogramming is one of the hallmarks of cancer. As nutrients are scarce in the tumor microenvironment (TME), tumor cells adopt multiple...

    Shiming Tan, Yiqing Yang, ... Yujuan Zhou in Journal of Experimental & Clinical Cancer Research
    Article Open access 10 March 2023
  7. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    Background

    Previous studies have shown that functional systemic immunity is required for the efficacy of PD-1/PD-L1 blockade immunotherapies in...

    Ester Blanco, Noelia Silva-Pilipich, ... Grazyna Kochan in British Journal of Cancer
    Article Open access 09 January 2024
  8. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression

    Background

    Lactate has emerged as a critical regulator within the tumor microenvironment, including glioma. However, the precise mechanisms underlying...

    Chaolong Yan, Zijiang Yang, ... **aobiao Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 04 April 2024
  9. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling

    Background

    Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and chemotherapy still serves as the cornerstone...

    Shengqi Wang, **g Li, ... Zhiyu Wang in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 April 2024
  10. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy

    Background

    Tumor-associated macrophages, as the major immunocytes in solid tumors, show divided loyalty and remarkable plasticity in tumorigenesis....

    Liang Li, Si-Rui Ma, Zi-Li Yu in Cellular Oncology
    Article 30 September 2023
  11. Oncofetal reprogramming in tumour development and progression

    Embryonic development is characterized by rapidly dividing cells, cellular plasticity and a highly vascular microenvironment. These features are...

    Ankur Sharma, Camille Blériot, ... Florent Ginhoux in Nature Reviews Cancer
    Article 23 August 2022
  12. Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells

    Metabolic reprogramming, which is recognized as a hallmark of cancer, refers to the phenomenon by which cancer cells change their metabolism to...

    Kang Wang, Yan Lu, ... Manzhao Ouyang in Cancer Cell International
    Article Open access 06 January 2024
  13. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities

    Tumor-associated macrophages (TAMs) are a heterogeneous population that play diverse functions in tumors. Their identity is determined not only by...

    Yu**g Qian, Yujia Yin, ... **peng Wang in Biomarker Research
    Article Open access 07 January 2024
  14. LncRNA CRNDE promotes hepatoma cell proliferation by regulating the metabolic reprogramming of M2 macrophages via ERK pathway

    Background

    LncRNA colorectal neoplasia differentially expressed (CRNDE) was found to be an important regulator in many cancers. This project focuses...

    Chao Lin, Tao Jiang, ... Yien **ang in Cancer Cell International
    Article Open access 31 May 2024
  15. Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

    Background

    Recently, we reported that tamoxifen-resistant (TAM-R) breast cancer cells are cross-resistant to irradiation. Here, we investigated the...

    F. V. Reinema, F. C. G. J. Sweep, ... P. N. Span in Cancer & Metabolism
    Article Open access 08 February 2023
  16. Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

    The tumor microenvironment (TME) is essential for immune escape by tumor cells. It plays essential roles in tumor development and metastasis. The...

    Ke Liu, Jia-Jia Cui, ... Ji-Ye Yin in Molecular Cancer
    Article Open access 11 April 2022
  17. Reprogramming of sentinel lymph node microenvironment during tumor metastasis

    Metastasis is a major cause of death in patients with cancer. The two main routes for cancer cell dissemination are the blood and lymphatic systems....

    Yen-Liang Li, Wen-Chun Hung in Journal of Biomedical Science
    Article Open access 20 October 2022
  18. Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling

    M2-like tumor-associated macrophages (TAMs) are risk factors for cancer progression and metastasis. However, the mechanisms underlying their...

    Seul Gi Lee, Seon Min Woo, ... Taeg Kyu Kwon in Experimental & Molecular Medicine
    Article Open access 01 February 2024
  19. FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis

    Purpose

    Macrophages (MΦs) play a dual role in the promotion and suppression of lung adenocarcinoma (LUAD), the function of which is influenced by the...

    Yiwei Huang, Guangyao Shan, ... Cheng Zhan in Cellular Oncology
    Article 12 October 2022
  20. 2′,3′,4′-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism

    Background

    Menopausal hormone therapy (MHT) is recommended for only five years to treat vasomotor symptoms and vulvovaginal atrophy because of safety...

    Candice B. Herber, Chaoshen Yuan, ... Dale C. Leitman in Molecular Medicine
    Article Open access 25 April 2022
Did you find what you were looking for? Share feedback.